pemafibrate
Kowa Pharmaceuticals
['cardio']
icymi: [pemafibrate] did not reduce cv event rates in patients with type 2 diabetes, mild to moderate hypertriglyceridemia, low hdl and well-controlled ldl cholesterol, #aha22 #cardiotwitter 
The content you need, when you need it.